These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7322498)

  • 21. A probable role for vaccines containing thimerosal in thimerosal hypersensitivity.
    Osawa J; Kitamura K; Ikezawa Z; Nakajima H
    Contact Dermatitis; 1991 Mar; 24(3):178-82. PubMed ID: 1868700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular hypersensitivity to thimerosal in rabbits.
    Baines MG; Cai F; Backman HA
    Invest Ophthalmol Vis Sci; 1991 Jul; 32(8):2259-65. PubMed ID: 2071338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute laryngeal obstruction presumed secondary to thiomersal (merthiolate) delayed hypersensitivity.
    Maibach H
    Contact Dermatitis; 1975 Aug; 1(4):221-2. PubMed ID: 1235252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitivity to contact lens solutions.
    Miller JR
    West J Med; 1984 May; 140(5):791. PubMed ID: 6730497
    [No Abstract]   [Full Text] [Related]  

  • 25. Elicitation of contact lens allergy to thimerosal by eye cream.
    Whittington CV
    Contact Dermatitis; 1985 Sep; 13(3):186. PubMed ID: 2932285
    [No Abstract]   [Full Text] [Related]  

  • 26. Contact dermatitis from merthiolate.
    Melino M; Antonelli C; Barone M
    Contact Dermatitis; 1986 Feb; 14(2):125. PubMed ID: 3709153
    [No Abstract]   [Full Text] [Related]  

  • 27. Reactions to thimerosal in hepatitis B vaccines.
    Rietschel RL; Adams RM
    Dermatol Clin; 1990 Jan; 8(1):161-4. PubMed ID: 2137393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thiomersal.
    Wilkinson DS
    Contact Dermatitis; 1979 Jan; 5(1):58-9. PubMed ID: 421465
    [No Abstract]   [Full Text] [Related]  

  • 29. Adverse external ocular effects of topical ophthalmic therapy: an epidemiologic, laboratory, and clinical study.
    Wilson FM
    Trans Am Ophthalmol Soc; 1983; 81():854-965. PubMed ID: 6676985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic reactions due to thiomersal.
    Tosti A; Melino M; Bardazzi F
    Contact Dermatitis; 1986 Sep; 15(3):187-8. PubMed ID: 2946540
    [No Abstract]   [Full Text] [Related]  

  • 31. Ocular sensitivity to thimerosal: a problem with hepatitis B vaccine?
    Kirkland LR
    South Med J; 1990 May; 83(5):497-9. PubMed ID: 2140468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Merthiolate allergy: a nationwide iatrogenic sensitization.
    Möller H
    Acta Derm Venereol; 1977; 57(6):509-17. PubMed ID: 73326
    [No Abstract]   [Full Text] [Related]  

  • 33. Merthiolate hypersensitivity and vaccination.
    Förström L; Hannuksela M; Kousa M; Lehmuskallio E
    Contact Dermatitis; 1980 Jun; 6(4):241-5. PubMed ID: 6447032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allergic contact dermatitis from mercury antiseptics and derivatives: study protocol of tolerance to intramuscular injections of thimerosal.
    Audicana MT; Muñoz D; del Pozo MD; Fernández E; Gastaminza G; Fernández de Corres L
    Am J Contact Dermat; 2002 Mar; 13(1):3-9. PubMed ID: 11887097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thimerosal: an ophthalmic preservative which acts as a hapten to elicit specific antibodies and cell mediated immunity.
    Cai F; Backman HA; Baines MG
    Curr Eye Res; 1988 Apr; 7(4):341-51. PubMed ID: 3371072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bandage lenses and the use of topical solutions containing preservatives.
    Lemp MA
    Ann Ophthalmol; 1978 Oct; 10(10):1319-21. PubMed ID: 718037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contact lens wear problems: implications of penicillin allergy, diabetic relatives, and use of birth control pills.
    Harrison DP
    Am J Optom Physiol Opt; 1984 Nov; 61(11):674-8. PubMed ID: 6517123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitization to thimerosal in atopic children.
    Patrizi A; Rizzoli L; Vincenzi C; Trevisi P; Tosti A
    Contact Dermatitis; 1999 Feb; 40(2):94-7. PubMed ID: 10048654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review on the toxicity of ethylmercury, including its presence as a preservative in biological and pharmaceutical products.
    Magos L
    J Appl Toxicol; 2001; 21(1):1-5. PubMed ID: 11180274
    [No Abstract]   [Full Text] [Related]  

  • 40. Allergic contact dermatitis from a vasoconstrictor cream.
    Landa N; Aguirre A; Goday J; Ratón JA; Díaz-Pérez JL
    Contact Dermatitis; 1990 May; 22(5):290-1. PubMed ID: 2143447
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.